HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.

Abstract
Synthetic progesterone used in contraception drugs (progestins) can promote breast cancer growth, but the mechanisms involved are unknown. Moreover, it remains unclear whether cytoplasmic interactions between the progesterone receptor (PR) and estrogen receptor alpha (ERα) are required for PR activation. In this study, we used a murine progestin-dependent tumor to investigate the role of ERα in progestin-induced tumor cell proliferation. We found that treatment with the progestin medroxyprogesterone acetate (MPA) induced the expression and activation of ERα, as well as rapid nuclear colocalization of activated ERα with PR. Treatment with the pure antiestrogen fulvestrant to block ERα disrupted the interaction of ERα and PR in vitro and induced the regression of MPA-dependent tumor growth in vivo. ERα blockade also prevented an MPA-induced increase in CYCLIN D1 (CCND1) and MYC expression. Chromatin immunoprecipitation studies showed that MPA triggered binding of ERα and PR to the CCND1 and MYC promoters. Interestingly, blockade or RNAi-mediated silencing of ERα inhibited ERα, but not PR binding to both regulatory sequences, indicating that an interaction between ERα and PR at these sites is necessary for MPA-induced gene expression and cell proliferation. We confirmed that nuclear colocalization of both receptors also occurred in human breast cancer samples. Together, our findings argued that ERα-PR association on target gene promoters is essential for progestin-induced cell proliferation.
AuthorsSebastián Giulianelli, José P Vaqué, Rocío Soldati, Victoria Wargon, Silvia I Vanzulli, Rubén Martins, Eduardo Zeitlin, Alfredo A Molinolo, Luisa A Helguero, Caroline A Lamb, J Silvio Gutkind, Claudia Lanari
JournalCancer research (Cancer Res) Vol. 72 Issue 9 Pg. 2416-27 (May 01 2012) ISSN: 1538-7445 [Electronic] United States
PMID22396492 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Copyright©2012 AACR
Chemical References
  • Estrogen Receptor alpha
  • Receptors, Progesterone
  • Cyclin D1
  • Fulvestrant
  • Estradiol
  • Medroxyprogesterone Acetate
Topics
  • Animals
  • Breast Neoplasms (genetics, metabolism, pathology)
  • Cell Growth Processes (genetics)
  • Cell Nucleus (genetics, metabolism)
  • Cyclin D1 (genetics)
  • Estradiol (analogs & derivatives, pharmacology)
  • Estrogen Receptor alpha (antagonists & inhibitors, genetics, metabolism)
  • Female
  • Fulvestrant
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Genes, Reporter
  • Genes, myc
  • Humans
  • Mammary Neoplasms, Experimental (genetics, metabolism, pathology)
  • Medroxyprogesterone Acetate (pharmacology)
  • Mice
  • Mice, Inbred BALB C
  • Neoplasms, Hormone-Dependent (genetics, metabolism, pathology)
  • Promoter Regions, Genetic
  • Receptors, Progesterone (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: